According to a recent report by Fact.MR, the demand for polymer chain reaction tests is expected to reach US$ 3.6 billion by the end of 2021 and is expected to reach US$ 12 billion by the end of the assessment period from 2021 to 2031. The polymerase chain reaction market (ポリメラエ連鎖电影市場) is threefold, with PCR reagents expected to account for 60% of total revenue.

In the field of medical diagnosis and biotechnology, polymerase chain reaction (PCR) technology has become an indispensable tool. Its importance has been further emphasized by recent advances in healthcare and the need for accurate and rapid testing, especially in the wake of the COVID-19 pandemic. Riding the wave of these healthy advances, the global polymerase chain reaction market has seen significant growth.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐚 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐓𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭
https://www.factmr.com/connectus/sample?flag=S&rep_id=4861 

𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬:

  • Bio-Rad Laboratories Inc.
  • Qiagen N.V
  • Roche Diagnostics
  • Becton Dickinson & Company (BD)
  • Abbott Laboratories
  • Siemens Healthineers
  • BioMerieux S.A
  • Danaher Corporation
  • Thermo Fisher Scientific Inc.
  • Agilent Technologies

𝐓𝐡𝐞 𝐏𝐂𝐑 𝐑𝐞𝐯𝐨𝐥𝐮𝐭𝐢𝐨𝐧

The polymerase chain reaction, developed by Kary B. Mullis in 1983, revolutionized the way scientists study and diagnose genetic diseases. This technology allows DNA to be amplified, making it easier to detect even small amounts of genetic material. Over the years, PCR has become a cornerstone of molecular biology, genetic research, forensics and clinical diagnosis.

𝐊𝐞𝐲 𝐃𝐫𝐢𝐯𝐞𝐫𝐬 𝐨𝐟 𝐆𝐫𝐨𝐰𝐭𝐡

  • COVID-19 testing: The ongoing pandemic has been a major catalyst for the impressive growth of the PCR market. PCR-based tests have been at the forefront of COVID-19 diagnosis, offering high sensitivity and specificity. Governments and health organizations worldwide rely heavily on PCR tests for mass screening and patient diagnosis.
  • Genomic research: PCR plays a central role in genomic research, where it is used to study genetic mutations, gene expression and DNA sequencing. With the continued expansion of the field of genomics, the demand for PCR technology has increased.
  • Molecular diagnosis: PCR has found wide applications in the diagnosis of various diseases such as cancer, infectious diseases and genetic disorders. The accuracy and speed of PCR-based diagnostics have made it a key tool in clinical laboratories.
  • Technological Advances: Continuous innovations in PCR technology have led to faster, more efficient and more user-friendly instruments. Real-time PCR, digital PCR and multiplex PCR are some of the advances that have improved PCR capabilities.
  • Point-of-care tests: the demand for PCR tests has increased, especially in the rapid mode. and on-site diagnostics. This has opened up new opportunities for market growth responding to the need for rapid results in clinical settings.

𝐂𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐢𝐯𝐞 𝐋𝐚𝐧𝐝𝐬𝐜𝐚𝐩𝐞:

Leading industry players are adopting innovative strategies, including groundbreaking marketing approaches, technological advancements, and mergers and acquisitions, to expand their market presence.

In October 2021, Thermo Fisher Scientific, a US-based provider of scientific instrumentation, reagents, and consumables, introduced the Applied Biosystem QuantStudio Absolute Q-Digital PCR System. This marked the debut of a fully integrated digital PCR (dPCR) system designed to deliver highly accurate and consistent results in genetic analysis and research, all within a remarkable 90-minute timeframe.

In March 2021, Agilent Technologies Inc. announced the launch of a real-time reverse transcription (qRT) PCR-based diagnostic kit for the detection of SARS-CoV-2 RNA. This kit has received the CE-IVD mark in compliance with the European Union In-Vitro Diagnostic Directive 98/79/EC and is readily available for distribution.

𝐊𝐞𝐲 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐬 𝐂𝐨𝐯𝐞𝐫𝐞𝐝

  • By Product
    • PCR Instruments
    • Standard PCR Systems
    • RT PCR Systems
    • Digital PCR Systems
    • PCR Reagents
    • PCR Consumables
  • By End User
    • PCR for Pharmaceutical & Biotechnology Industries
    • PCR for Clinical Diagnostics Labs and Hospitals
    • PCR for Academic and Research Organizations
    • PCR for Other End Users
  • By Regions 
    • North America
    • Latin America
    • Europe
    • East Asia
    • South Asia
    • Oceania
    • Middle East & Africa

The global Polymerase Chain Reaction market has experienced impressive growth, driven by its essential role in healthcare advancements, particularly in the context of the COVID-19 pandemic. With ongoing technological innovations and expanding applications, PCR technology is set to remain at the forefront of molecular diagnostics and genetic research, offering hope for more effective disease diagnosis and management in the future.

Contact: 
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
Email: sales@factmr.com